Category: <span>Stem Cell Therapy</span>

Home / Stem Cell Therapy
Post

FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis

U.S. Phase 2 Study to Begin in First Quarter of 2019 NEW YORK, Dec. 17, 2018 — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application...

Post

Maintaining the unlimited potential of stem cells

Salk scientists discover new protein complex that keeps embryonic stem cells at stage of fullest potential, a key to regenerative medicine SALK INSTITUTE LA JOLLA–(December 11, 2018) Embryonic stem cells (ESCs) are the very definition of being full of potential, given that they can become any type of cell in the body. Once they start...

Post

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1. Dr Bing Hu. Credit: University of Plymouth Dr. Bing Hu from Plymouth’s Institute of Translational and Stratified Medicine (ITSMed), together with Dr. Denis Corbeil from the Technische...

Post

Stem cell researchers develop promising technique to generate new muscle cells in lab

UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports. IMAGE: UTHEALTH STEM CELL RESEARCHERS, FROM THE LEFT, ARE NADINE MATTHIAS, DVM; JIANBO WU, PH.D.; RADBOD DARABI, M.D., PH.D.; AND...

Post

Treating the ‘bubble babies’

An international study published in the journal Blood by researchers led by Dr. Elie Haddad, a pediatric immunologist and researcher at CHU Sainte-Justine and professor at Université de Montréal, highlights the urgent need to develop better treatment strategies for patients suffering from severe combined immune deficiency (SCID). This deficiency, better known as “bubble baby disease”...

Post

Stem cells can differentiate into neurons and may be useful post-stroke therapeutics

Researchers have performed a careful comparison between locally generated, ischemia-induced, multipotent stem cells (iSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) in an effort to determine which cell type has greater central nervous system (CNS) repair capacity. Their results show that the iSC characteristics make them more promising candidates as CNS injury therapeutics. The study...